News
The CDC’s Advisory Committee on Immunization Practices (ACIP) has blessed Merck’s new respiratory syncytial virus (RSV) shot ...
The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially increased the demand for ...
The reduction in emphasis on the unbiased ascertainment of vaccine safety signals, and redirection toward certain specific ...
2d
Zacks Investment Research on MSNSanofi Trades Below 50 & 200-Day Moving Averages: Time to Buy the Dip?Sanofi’s SNY stock has been trading below its 200-day and 50-day moving averages since early June. On June 23, the stock’s ...
Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...
Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by ...
Global Vaccines Market Set to Grow at 9.80% CAGR Amid Rising Demand for Digital Healthcare Solutions
Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by 2035, representing a robust CAGR of 9.80%.Increasing prevalence of ...
Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...
Data from US safety monitoring systems for all COVID-19 vaccines authorised or approved by the FDA have been reviewed regularly by the ACIP COVID-19 Vaccines Safety Technical Work Group 20 and at ...
Ten studies evaluated the vaccine efficacy or effectiveness over time for SARS-CoV-2 infection, among which were 26 vaccine-specific analyses (Pfizer–BioNTech-Comirnaty, n=13; Moderna-mRNA-1273, n=9; ...
The latest health news covers FDA's extended review of KalVista's drug, UroGen's new bladder cancer treatment approval, ...
Rep Kim Schrier, MD, (D-Wash.), said on X yesterday that some of the newly appointed ACIP replacements are anti-vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results